DUBLIN–(BUSINESS WIRE)–The “Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.
The global sinus dilation devices market is anticipated to reach USD 3.8 Billion by 2027 from USD 2.8 billion in 2022, at a CAGR of 6.6%
The growth of the market is primarily driven by the factors such as growing extensiveness of chronic sinusitis and rising inclination of minimally invasive surgeries such as balloon sinuplasty.
The Sinus stents/implants is projected to grow at highest CAGR of 8.2% from 2022 to 2027
Based on the product, the sinus dilation devices market is classified into Balloon sinus dilation devices, Endoscopes (Sinuscopes, Rhinoscopes), Sinus stents/implants, and Handheld instruments. The growth of this market is majorly driven by the factors such as Advantages of balloon dilation procedures compared to traditional endoscopic sinus surgeries and Elevated regularity in chronic sinusitis.
Asia Pacific is estimated to register the highest CAGR during the forecast period
In this report, the sinus dilation devices market is branched into four significant regional segments such as, North America, Europe, Asia Pacific, and the Rest of the World (RoW).
The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising geriatric population, increasing per capita income and presence of low cost treatments.
Competitive landscape
Prominent players in the sinus dilation devices market include Acclarent, Inc. (a subsidiary of Johnson & Johnson) (US), Olympus Corporation (Japan), F. Entellus Medical Inc. (a subsidiary of Stryker) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT, Inc. (US), SinuSys Corporation (US), InnAccel Pvt. Ltd (India), Meril Life Sciences Pvt. Ltd. (India), and Optim LLC (US).
Premium Insights
High Prevalence of Chronic Sinusitis to Drive Market
Hospitals and ASCs Segment to Register Highest CAGR During Forecast Period
Balloon Sinus Dilation Devices Segment to Dominate Asia-Pacific Market in 2022
China to Register Highest CAGR During Forecast Period
Market Dynamics
Drivers
High Prevalence of Chronic Sinusitis
Benefits of Balloon Dilation Procedures Over Traditional Endoscopic Sinus Surgeries
Growing Preference for Minimally Invasive Surgeries
Rising Healthcare Expenditure
Increasing Availability of Reimbursements
Restraints
Risks Associated with Sinus Surgeries
Availability of Non-Surgical Treatments for Chronic Sinusitis
Opportunities
Growing Healthcare Market in Emerging Economies
Challenges
Dearth of Skilled Otolaryngologists, ENT Surgeons, and Endoscopists
Survival of Small Players and New Entrants
Company Profiles
Acclarent, Inc. (Subsidiary of Johnson & Johnson)
Angiplast Pvt. Ltd.
Cook Medical
Dalent Medical
Emos Technology GmbH
Entellus Medical, Inc. (Subsidiary of Stryker)
Entermed
Esc Medicams
Innaccel Technologies Pvt Ltd.
Intersect Ent, Inc.
Jilin Coronado Medical Ltd.
Karl Storz
Maxer Endoscopy GmbH
Medtronic plc
Meril Life Sciences Pvt. Ltd.
Olympus Corporation
Optim LLC
Pentax Medical
Richard Wolf GmbH
Scholly Fiberoptic GmbH
Sinusys Corporation
Sklar Surgical Instruments
Smith & Nephew plc
Summit Medical LLC
Xion GmbH
For more information about this report visit https://www.researchandmarkets.com/r/mq62wx
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
